A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
The aim of the reported trial was to investigate the safety and efficacy of memantine in mild to moderate vascular dementia (VaD). This was a 28-week, double-blind, parallel, randomized controlled trial of memantine 20 mg daily versus placebo which was conducted in 54 centres in the UK. Memantine is...
Main Authors: | Wilcock, G, Möbius, H, Stöffler, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registos relacionados
-
Memantine for the treatment of dementia.
Por: Wilcock, G
Publicado em: (2003) -
Memantine for dementia.
Por: Mcshane, R, et al.
Publicado em: (2006) -
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Por: Hanney, M, et al.
Publicado em: (2012) -
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
Por: Majed Al-Jeraisy, et al.
Publicado em: (2021-04-01) -
A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
Por: Kieburtz, K, et al.
Publicado em: (2013)